Similar companies
| Company | Stocktwits Subscribers | |
|---|---|---|
 |
AmgenAMGN |
15,004 0% |
 |
Gilead SciencesGILD |
77,596 0% |
 |
Catalyst PharmaceuticalsCPRX |
15,493 0% |
 |
Inovio PharmaceuticalsINO |
92,242 0% |
 |
Anavex Life SciencesAVXL |
23,924 0% |
Intellia Therapeutics Stocktwits Subscriber Count
Intellia Therapeutics (NTLA) has 15,293 subscribers on Stocktwits, roughly flat (+1.3%) over the past three months.
With 15,293 subscribers, Intellia Therapeutics leads Amgen (15,004) but trails Gilead Sciences (77,596).
Unlike daily Stocktwits mentions, which spike around news and earnings, subscriber count reflects sustained, long-term interest from the retail investor community.
How NTLA’s Stocktwits Community Feeds the AI Score
Stocktwits subscriber count is a direct read on the size of the retail investor community tracking NTLA. It is not a stock price on its own, but sustained growth in subscribers can reflect building retail interest. AltIndex feeds Intellia Therapeutics’s Stocktwits community into the NTLA AI Score as one of 25+ alternative data signals, weighed against sentiment, Reddit activity, and fundamentals.
For daily discussion volume, see NTLA Stocktwits mentions. For other retail-community metrics, see Reddit subscribers and Reddit mentions.
Month over Month
| Sep 2026 | 15,233 | |
| Aug 2026 | 15,158 | |
| Jul 2026 | 15,116 | |
| Jun 2026 | 15,006 | |
| May 2026 | 14,972 | |
| Apr 2026 | 14,427 |
Intellia Therapeutics Stocktwits Subscribers: Frequently Asked Questions
Intellia Therapeutics (NTLA) has 15,293 subscribers (15K) on Stocktwits, based on AltIndex’s tracking of the stock’s Stocktwits page.
Intellia Therapeutics's Stocktwits subscriber base has been roughly flat (+1.3%) over the past three months. View the trend chart above for the full history.
Stocktwits subscriber count is a proxy for the size of the retail investor community tracking a stock. Unlike daily mentions, which spike around news, subscriber growth reflects sustained interest. No single data point predicts a stock on its own, which is why AltIndex combines NTLA’s Stocktwits community with sentiment, Reddit activity, and 20+ other signals in its AI Score rather than reading any one signal in isolation.
Intellia Therapeutics underperforms its industry peers when it comes to Stocktwits Subscribers, ranking in the 10th percentile.
StockTwits is a social media platform designed specifically for the investing community. It enables investors and traders to share market insights, strategies, and real-time news updates. Essentially, it's a specialized network for financial market discussions, often characterized by brief, tweet-like posts.
Sign up and get more insights on Intellia Therapeutics.
See Intellia Therapeutics’s complete stocktwits subscribers history
Sign up to unlock 1-year and all-time charts for NTLA, plus 25+ alternative data signals, AI Scores, and real-time alerts.
Get Started for FREE
